Annual report pursuant to Section 13 and 15(d)

Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.20.4
Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Non-capital losses carried forward $ 14,321 $ 11,211
Research and development expenditures 817 817
Share issue costs 837 395
Patents and other 300 294
Accruals 6 13
Property and equipment (14)  
Property and equipment   3
Total deferred tax asset, net 16,267 12,733
Valuation allowance (16,267) (12,733)
Net deferred tax asset